On April 30, 2024, Dong'e Ejiao disclosed in the Shenzhen Stock Exchange that as of April 19, 2024, the number of shareholders of the company was 43,900, an increase of 706 or 1.63% from the previous period (April 10, 2024).
The number of shareholders of Dong'e Ejiao is higher than the industry average. According to Choice data, as of April 19, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.84%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 20, 2024, the number of shareholders of the company has increased, with an increase of 0.79%. From March 20, 2024 to April 19, 2024, the stock price increased by 14.83%.
Number of shareholders and share price
Number of shareholders and share capital
As of April 19, 2024, the company's latest total share capital is 644 million shares, all of which are outstanding shares. The average number of outstanding shares held by households decreased from 14,900 shares in the previous period to 14,700 shares, and the average market value of households was 1.019 million yuan.
The average amount of shares held by each household
The circulating market value of Dong'e Ejiao households is higher than the industry average. According to Choice data, as of April 19, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 400,300 yuan. Among them, 25.31% of the company's households hold a circulating stock market value in the range of 130,000~250,000.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
SZSE shareholdings
On April 19, 2024, the number of shares held by SZSE was 60.755 million shares, accounting for 9.43% of the outstanding share capital, an increase of 0.34% from 60.547 million shares in the previous period (April 10, 2024).
SZSE shareholding chart
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.